-
Product Insights
New![]()
Net Present Value Model: I-Mab’s Felzartamab
Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Product Insights
New![]()
Net Present Value Model: I-Mab’s Plonmarlimab
Overview Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Product Insights
New![]()
Net Present Value Model: I-Mab’s Uliledlimab
OverviewDetermining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Product Insights
New![]()
Net Present Value Model: I-Mab’s Lemzoparlimab
Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – MTL-CEBPA in Mucopolysaccharidosis I (MPS I) (Hurler Syndrome )
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. MTL-CEBPA in Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) Drug Details: MTL-CEBPA is under development...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – OTL-203 in Mucopolysaccharidosis I (MPS I) (Hurler Syndrome )
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.OTL-203 in Mucopolysaccharidosis I (MPS I) (Hurler Syndrome )Drug Details:OTL-203 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – ISP-001 in Mucopolysaccharidosis I (MPS I) (Hurler Syndrome )
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.ISP-001 in Mucopolysaccharidosis I (MPS I) (Hurler Syndrome )Drug Details:ISP-001 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – RGX-111 in Mucopolysaccharidosis I (MPS I) (Hurler Syndrome )
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.RGX-111 in Mucopolysaccharidosis I (MPS I) (Hurler Syndrome )Drug Details:RGX-111 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Lepunafusp alfa in Mucopolysaccharidosis I (MPS I) (Hurler Syndrome )
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Lepunafusp alfa in Mucopolysaccharidosis I (MPS I) (Hurler Syndrome )Drug Details:JR-171 is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Pentosan Polysulfate Sodium in Mucopolysaccharidosis I (MPS I) (Hurler Syndrome )
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Pentosan polysulfate sodium in Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) Drug Details: Pentosan...
-
Product Insights
Basra I Refinery, Iraq
Basra I refinery is located in Al-Basrah, Iraq. The refinery is owned by South Refineries Co. It is operated by South Refineries Co. The project started its operations in 1974. Basra I Refinery profile includes core details such as name, location, refinery type, asset status, start year, owner and equity stakes, operator, design/nameplate capacities of different processing units for the period 2010-2030, nelson complexity index (NCI) and capex. We also provide refinery maintenance information for active refineries (both historic and...
-
Product Insights
Angarsk I Refinery, Russia
Angarsk I refinery is located in Irkutsk Oblast, Russia. The refinery is owned by Rosneft Oil Co. It is operated by Angarsk Petrochemical Co. The project started its operations in 1955. Angarsk I Refinery profile includes core details such as name, location, refinery type, asset status, start year, owner and equity stakes, operator, design/nameplate capacities of different processing units for the period 2010-2030, nelson complexity index (NCI) and capex. We also provide refinery maintenance information for active refineries (both historic...
-
Product Insights
Sohar I Refinery, Oman
Sohar I refinery is located in Al Batinah North Governorate, Oman. The refinery is owned by OQ SAOC. It is operated by OQ Refineries and Petroleum Industries LLC. The project started its operations in 2006. Sohar I Refinery profile includes core details such as name, location, refinery type, asset status, start year, owner and equity stakes, operator, design/nameplate capacities of different processing units for the period 2010-2030, nelson complexity index (NCI) and capex. We also provide refinery maintenance information for...
-
Product Insights
Rotterdam I Refinery, Netherlands
Rotterdam I refinery is located in South Holland, Netherlands. The refinery is owned by Exxon Mobil Corp. It is operated by ExxonMobil Fuels and Lubricants Co. The project started its operations in 1960. Rotterdam I Refinery profile includes core details such as name, location, refinery type, asset status, start year, owner and equity stakes, operator, design/nameplate capacities of different processing units for the period 2010-2030, nelson complexity index (NCI) and capex. We also provide refinery maintenance information for active refineries...
-
Product Insights
Abadan I Refinery, Iran
Abadan I refinery is located in Khuzestan, Iran. The refinery is owned by National Iranian Oil Refining and Distribution Co. It is operated by National Iranian Oil Refining and Distribution Co. The project started its operations in 1912. Abadan I Refinery profile includes core details such as name, location, refinery type, asset status, start year, owner and equity stakes, operator, design/nameplate capacities of different processing units for the period 2010-2030, nelson complexity index (NCI) and capex. We also provide refinery...
-
Product Insights
Skikda I Refinery, Algeria
Skikda I refinery is located in Skikda, Algeria. The refinery is owned by Sonatrach SpA. It is operated by Sonatrach SpA. The project started its operations in 1980. Skikda I Refinery profile includes core details such as name, location, refinery type, asset status, start year, owner and equity stakes, operator, design/nameplate capacities of different processing units for the period 2010-2030, nelson complexity index (NCI) and capex. We also provide refinery maintenance information for active refineries (both historic and forecast), along-with...
-
Product Insights
Antwerp I Refinery, Belgium
Antwerp I refinery is located in Antwerp, Belgium. The refinery is owned by TotalEnergies SE. It is operated by TotalEnergies SE. The project started its operations in 1951. Antwerp I Refinery profile includes core details such as name, location, refinery type, asset status, start year, owner and equity stakes, operator, design/nameplate capacities of different processing units for the period 2010-2030, nelson complexity index (NCI) and capex. We also provide refinery maintenance information for active refineries (both historic and forecast), along-with...
-
Product Insights
Tula I Refinery, Mexico
Tula I refinery is located in Hidalgo, Mexico. The refinery is owned by Petroleos Mexicanos. It is operated by Petroleos Mexicanos. The project started its operations in 1977. Tula I Refinery profile includes core details such as name, location, refinery type, asset status, start year, owner and equity stakes, operator, design/nameplate capacities of different processing units for the period 2010-2030, nelson complexity index (NCI) and capex. We also provide refinery maintenance information for active refineries (both historic and forecast), along-with...
-
Product Insights
Moscow I Refinery, Russia
Moscow I refinery is located in Moscow Oblast, Russia. The refinery is owned by Gazprom. It is operated by AO Gazpromneft MNPZ. The project started its operations in 1938. Moscow I Refinery profile includes core details such as name, location, refinery type, asset status, start year, owner and equity stakes, operator, design/nameplate capacities of different processing units for the period 2010-2030, nelson complexity index (NCI) and capex. We also provide refinery maintenance information for active refineries (both historic and forecast),...
-
Product Insights
